Plain-English translation of NCT06298188 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a one-year study that follows children with Crohn's disease who are starting , a newer medication designed to help control the disease. Researchers will track how well the medication works, check for side effects, and collect blood and stool samples to understand what's happening in your child's body. The study will also follow participants for up to 2 additional years to see long-term results.
While this medication has been approved and used in adults, doctors want to better understand how well it actually works in real-world situations with children and whether it can help reduce symptoms and inflammation over time. This study will help doctors learn more about the benefits and safety of this treatment in young patients.
You likely qualify if…
You likely don't qualify if…
Your child will receive the medication as prescribed by their doctor—an IV infusion at weeks 0, 4, and 8, then shots under the skin every 8 weeks after that. You'll have regular appointments over one year to check how your child is doing, provide blood samples, and collect stool samples. Doctors will ask about symptoms, watch for any side effects, and measure inflammation markers to see if the treatment is helping.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Israel
Sponsor
Shaare Zedek Medical Center
Enrollment target
~90 participants
Started
October 2024
Primary completion
October 2026
Age range
6 Years – 18 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nataly Kawazba
Shaare Zedek Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.